Home / Inspections / 1021119

FDA Inspection 1021119 — Carter BloodCare at Lockheed

Carter BloodCare at Lockheed — FEI 3002965640

The FDA completed an inspection of Carter BloodCare at Lockheed on July 18, 2017 in White Settlement, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
White Settlement, TX (United States)

Facility

Other inspections at this facility

  • 1247270 (NAI Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079842 (NAI Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910023 (NAI Thu Jan 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802681 (NAI Wed Oct 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694616 (NAI Sat Oct 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources